ETF Securities (ASX:CURE) ETF. The ETFS CURE ETF provides investors with exposure to the US biotechnology sub-industry within the health care sector. CURE adopts an equally weighted strategy, which allocates greater exposure to small and mid-cap shares compared to a market capitalisation weighted approach.View our FULL REPORT on ETF Securities CURE ETF (ASX:CURE).
On The Australian Investors Podcast today, Owen Rask is joined by Blair Hannon of Global X ETFs to talk about the ways to play investing in Artificial Intelligence (AI). The duo talk about ETFs, stocks like NVIDIA, TECH, FANG and more.
Biotechnology has experienced extraordinary growth in recent times and came to popular attention as companies raced to find vaccines and cures for COVID-19.
In this episode of The Australian Finance Podcast, Owen talks with ETF Securities CEO, Kris Walesby, about his journey, where ETFs came from, the Core
One ASX ETF that could boost the returns of your portfolio is the ETFS S&P Biotech ETF (ASX: CURE). Here are some of the opportunities and risks.
